2 нояб. 2017 г. · ORBITA is a blinded, multicentre randomised trial of PCI versus a placebo procedure for angina relief that was done at five study sites in ... |
11 нояб. 2023 г. · The ORBITA-2 trial was an investigator-initiated, multicenter, double-blind, randomized, placebo-controlled trial that was conducted at 14 sites ... |
29 июн. 2022 г. · The ORBITA trial showed that among patients with stable angina, PCI does not result in greater improvements in exercise times or anginal frequency compared ... |
6 янв. 2018 г. · ORBITA is a blinded, multicentre randomised trial of PCI versus a placebo procedure for angina relief that was done at five study sites in the UK. |
32714-9/asset/8d2205db-cd55-4221-b17c-cdbaa5a5a574/main.assets/gr1_lrg.jpg)
The results of the ORBITA trial showed that, in patients with stable angina, PCI does not result in greater improvements in exercise times or chest pain ... |
2 нояб. 2017 г. · ORBITA randomized 200 patients with severe (≥70%) single-vessel stenoses to either PCI (n=105) or placebo (n=95) using a blinded sham procedure. |
The recently published ORBITA trial compared OMT + PCI with OMT + 'placebo' PCI in patients with angina and single-vessel coronary artery disease (CAD). |
11 нояб. 2023 г. · ORBITA-2 is the first placebo-controlled trial to confirm the benefit of percutaneous coronary intervention (PCI) for patients with stable ischemic heart ... |
ORBITA-2 is a randomized controlled trial assessing the placebo-controlled efficacy of PCI for relieving angina in patients with single- or multi-vessel ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |